A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

ClinicalTrials.gov ID: NCT07659795

Public ClinicalTrials.gov record NCT07659795. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 12:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Open-label Study of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, With and Without an Anti-EGFR Antibody, and With an Anti-EGFR Antibody and Chemotherapy, in Patients With Metastatic KRAS G12D-Mutated Colorectal Adenocarcinoma (TARGET-D 203)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab or panitumumab and cetuximab plus mFOLFOX in patients with metastatic KRAS G12D - mutated Colorectal Cancer

Study identification

NCT ID: NCT07659795
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Verastem, Inc.; Industry
Enrollment: 150 participants

Conditions and interventions

Conditions

Colorectal Cancer

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 28, 2026 (Actual)
Primary completion: Jun 2027 (Estimated)
Completion: Dec 2028 (Estimated)
Last update posted: Oct 21, 2026

2026 – 2028

United States locations

U.S. sites: 22
U.S. states: 16
U.S. cities: 20

Facility	City	State	ZIP	Site status
HonorHealth	Scottsdale	Arizona	85258	Recruiting
START Los Angeles	Los Angeles	California	90025	Recruiting
Cedars-Sinai Medical Center	Los Angeles	California	90048	Recruiting
Valkyrie Clinical Trials (contact for more locations)	Los Angeles	California	90067	Recruiting
BRCR - Tamarac	Tamarac	Florida	33321	Recruiting
Moffitt Cancer Center	Tampa	Florida	33612	Recruiting
Indiana University, Simon Comprehensive Cancer Center	Indianapolis	Indiana	46202	Recruiting
START Midwest	Grand Rapids	Michigan	49546	Recruiting
Washington University	St Louis	Missouri	63110	Recruiting
START New Jersey	East Brunswick	New Jersey	08816	Recruiting
Perlmutter Cancer Center at NYU Langone Health (contact for more locations)	New York	New York	10016	Recruiting
University of North Carolina	Chapel Hill	North Carolina	27514	Recruiting
Case Western, University Hospitals Cleveland Medical Center	Cleveland	Ohio	44106	Recruiting
Sarah Cannon Research Institute Oncology Partners	Nashville	Tennessee	37203	Recruiting
START Dallas Fort Worth	Fort Worth	Texas	76104	Recruiting
The University of Texas MD Anderson Cancer Center	Houston	Texas	77030	Recruiting
Huntsman Cancer Institute - University of Utah	Salt Lake City	Utah	84112	Recruiting
START Mountain Region	West Valley City	Utah	84119	Recruiting
UVA Comprehensive Cancer Center	Charlottesville	Virginia	22908	Recruiting
Virginia Cancer Specialists	Fairfax	Virginia	22031	Recruiting
Virginia Mason Medical Center	Seattle	Washington	98101	Recruiting
University of Wisconsin	Madison	Wisconsin	53792	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07659795, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 21, 2026 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07659795 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →